Growth Metrics

Oscar Health (OSCR) Depreciation & Amortization (CF) (2020 - 2025)

Oscar Health's Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $7.9 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 14.57% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $28.9 million, down 10.09%, while the annual FY2025 figure was $28.9 million, 10.09% down from the prior year.
  • Depreciation & Amortization (CF) reached $7.9 million in Q4 2025 per OSCR's latest filing, up from $7.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $9.2 million in Q4 2024 to a low of $3.4 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $6.1 million, with a median of $6.8 million recorded in 2025.
  • Peak YoY movement for Depreciation & Amortization (CF): soared 139.01% in 2023, then fell 18.4% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $4.0 million in 2021, then dropped by 5.49% to $3.8 million in 2022, then soared by 106.34% to $7.7 million in 2023, then grew by 19.26% to $9.2 million in 2024, then dropped by 14.57% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for OSCR's Depreciation & Amortization (CF) are $7.9 million (Q4 2025), $7.3 million (Q3 2025), and $7.0 million (Q2 2025).